Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04805437

Brace Treatment for Idiopathic Scoliosis; PReventing Idiopathic SCOliosis PROgression

Idiopathic scoliosis is the most common spinal deformity in children and adolescents with an estimated prevalence of 3%. About one tenth of the children with scoliosis develop a deformity that requires treatment with brace or surgery with the current treatment protocol. When brace treatment for scoliosis is indicated, standard treatment consists of bracing 20 hours or more per day. Outcomes of brace treatment depend to a large extent on wearing time and since many adolescents feel uncomfortable in the brace, it is of importance to combine efficacy and comfortability of the brace.

Recruiting

Interested in participating?

Request Info

Key information

Age range

9 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Linköping university hospital, Linköping, Sweden

Loading trial locations.

About this study

Bracing with a rigid TLSO is gold-standard treatment in terms of halting progression of idiopathic scoliosis in skeletally immature adolescents and children. The treatment is cumbersome and demanding for adolescents during a vulnerable stage in life, and may be associated with poor compliance. Furthermore, the treatment lasts in many cases for several years and has shown to have a negative psychological effect for patients. Since time in brace is of utmost importance for best possible outcome, the braces need to be tolerated by the patients. As of today, 3D designed braces have received much attention and are thought to increase comfortability and ultimately increase wearing time, leading to better outcomes.

In a multicenter randomized controlled trial, we seek to compare standard Boston brace to a newly developed 3D designed Boston brace. Skeletally immature patients with idiopathic scoliosis will be randomized to receive either standard Boston brace or Boston 3D brace. All patients will be encouraged to be physically active for 60 minutes per day. Patients, outcome assessors and clinician in charge during follow-ups will be blinded for the type of brace the patients are being treated with. Thermal sensors will be installed in all braces to monitor compliance. Outcome include change in curve severity, quality of life and surgical rates. Patients will be evaluated with clinical and radiological follow-ups every six months until skeletal maturity and thereafter at 2, 5 and 10 years. Curve progression will not lead to change of brace. A total of 85 individuals are required in each group based on the hypothesis of a 2% failure rate in the 3D-brace group and 15% in the standard brace group with 5% significance level and 80% power and consideration for dropout of up to 20%.

For individuals who are not willing to be randomized and participate in the study, standard Boston brace will be offered and these individuals will serve as an observational group with similar follow-ups and will be asked to answer same survey as the study populations will do.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Cobb 25-40 degrees
  • Skeletally immature, Sanders score of 6 or less and Risser 2 or less.
  • Menarche status maximum one year in females
  • Aged 9-17 years
  • No previous brace treatment or surgery for scoliosis
  • Apex of the primary curve at T7 or caudal

Exclusion criteria

  • Non-idiopathic scoliosis (i.e. neuromuscular, syndromic or congenital scoliosis)
  • Previous spine surgery

Treatment and study plan

3D TLSO

Device

Brace treatment with Boston 3D 20 hours a day until skeletal maturity.

Other names: Boston 3D brace

Standard TLSO

Device

Brace treatment with standard Boston brace 20 hours a day until skeletal maturity.

Other names: Boston brace

Primary outcomes

  1. Curve progression

    Time frame: Measured at each six-month follow-up until skeletal maturity. Skeletal maturity defined as less than 1 cm body height increase in 6 months.

    Increase in curve severity (Cobb angle) of more than 6 degrees on two consecutive radiographs after baseline

Secondary outcomes

  1. Clinical outcomes

    Time frame: At each six-month follow-up and 2, 5, 10 years after skeletal maturity

    Angle of trunk rotation in forward bending, assessed with scoliometer

  2. Patient-reported outcome measures

    Time frame: At each six-months follow-up and 2, 5, 10 years after skeletal maturity

    Scoliosis Research Society-22r questionnaire

  3. Patient-reported outcome measures

    Time frame: At each six-month follow-up, and 2, 5, 10 years after skeletal maturity

    EQ5D questionnaire

  4. Patient-reported outcome measures

    Time frame: At each six-month follow-up, and 2, 5, 10 years after skeletal maturity

    Spinal Appearance Questionnaire (SAQ)

  5. Patient-reported outcome measures

    Time frame: At each six-month follow-up, and 2, 5, 10 years after skeletal maturity

    International Physical Activity Questionnaire (IPAQ)

  6. Surgical rates

    Time frame: At each six-months follow-up and 2, 5, 10 years after skeletal maturity

    Number needing surgical intervention

Study contacts

Contact information is provided by the study sponsor or research team.

Elias Diarbakerli, PT, PhD

CONTACT

[email protected]

+460851770000

Paul Gerdhem, MD, PhD

CONTACT

[email protected]

Sponsors and collaborators

Lead sponsor

Karolinska Institutet

Other

Collaborators

  • Linkoeping University

Registry information

Official study title

3D Designed Boston Brace Versus Standard Boston Brace in Halting Progression in Idiopathic Scoliosis: a Randomized Controlled Trial

Acronym: PRISCOPRO

Important dates

Study start
2021
Primary completion
2027
Study completion
2037
First posted
Mar 18, 2021
Registry last updated
Feb 21, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.